Both in Pharmaceuticals
Actuate Therapeutics vs GT Biopharma
Over the past year ACTU returned −94.3% and GTBP returned −66.9%; their daily moves had a correlation of 0.08.
ACTU −94.3% GTBP −66.9%Growth of $1, one year, split-adjusted
| Metric | ACTU | GTBP |
|---|---|---|
| Price | $0.3833 | $5.51 |
| Market cap | $9.2M | $9.9M |
| Today | −4.06% | −1.25% |
| 1 month | −44.1% | −19.9% |
| 6 months | −86.7% | −19.0% |
| Year to date | −93.7% | −71.9% |
| 1 year | −94.7% | −68.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.4M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 162.7% | 958.3% |
| Short % of float | 19.2% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).